RAYDIANT OXIMETRY INC

Mountain View, CA · Founded 2016 · Medtech · Private

Non-invasive fetal oximetry device for real-time fetal oxygen saturation monitoring during pregnancy and labor

Claim this profile

Follows are private to you and power your alerts

Updated · raydiantoximetry.com

Sector
Medtech
Headquarters
Mountain View, CA
Founded
2016
Latest Form D
$4.3M, Jun 2024
Total capital
$18.8M
Federal grants
$5.3M
9 awards · 2018–2024
Rank in peer group#312 of 538
Private capital raised
$13.4M
7 Form D · last Jun 2024
29 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
16
24 pending · first 2017
Rank in peer group#33 of 538

Capital timeline

2018201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $18.8M$208K$225K$1.7M$856K$856K$872K6th Form D$2M7th Form D$4.3M
2018202020222024FEDERAL ↑EQUITY ↓Cumulative $18.8M$1.7M$856K$856K$872K7th Form D$4.3M

Latest events

  • Federal grantHealth and Human S · Phase II · Advancing Fetal Assessment during Labor with Transabdominal Fetal Oximetry$872K
  • Private capital raisedForm D · SEC · 7th filing$4.3M
  • Federal grantHealth and Human S · Phase II · Advancing Fetal Assessment during Labor with Transabdominal Fetal Oximetry$856K
  • Federal grantHealth and Human S · Phase II · Advancing Fetal Assessment during Labor with Transabdominal Fetal Oximetry$856K
  • Private capital raisedForm D · SEC · 6th filing$2M
  • Federal grantNSF · Phase II · SBIR Phase II: Optimization of non-invasive fetal oxygenation sensing hardware and algorithm$1.7M
  • Federal grantHealth and Human S · Phase I · Design and Development of Raydiant Oximetry Sensing Systems$203K
  • Private capital raisedForm D · SEC · 5th filing$50K
  • Private capital raisedForm D · SEC · 4th filing$900K
  • Private capital raisedForm D · SEC · 3rd filing$3.2M
  • Private capital raisedForm D · SEC · 2nd filing$2.5M
  • Private capital raisedForm D · SEC · 1st filing$493K
Show 4 earlier federal awards
  • Federal grantHealth and Human S · Phase I · Design and Development of Raydiant Oximetry Sensing Systems$203K
  • Federal grantNSF · Phase I · SBIR Phase I:Design and optimization of non-invasive fetal oxygenation sensing hardware and algorithm$225K
  • Federal grantHealth and Human S · Phase I · Validating novel optical-sensing technology for transabdominal fetal oximetry through pregnant ewe animal models.$208K
  • Federal grantHealth and Human S · Phase I · Validating novel optical-sensing technology for transabdominal fetal oximetry through pregnant ewe animal models.$208K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#33 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Neil P. RayResearcherExecutive Officer, DirectorLinked by $3M in grants as PI
  • Annie P. TheriaultDirectorNamed in SEC Form D filings
  • Charles P. McDonaldDirectorNamed in SEC Form D filings
  • Debra P. ReisenthelDirectorNamed in SEC Form D filings
  • Elizabeth P. BaileyDirectorNamed in SEC Form D filings
  • John P. MaroneyDirectorNamed in SEC Form D filings
Show all 8 people
  • Russ P. DeLonzorExecutive OfficerNamed in SEC Form D filings
  • Terri P. BurkeDirectorNamed in SEC Form D filings

What it has protected

USPTO · 16 granted of 40
Show all 40 patent records
  • Raydiant Oximetry, IncShares a founder: NEIL RAY
  • Oralucent, Inc.Similar federal contract value in Medtech · null in contracts
  • INDEPTH PHARMACEUTICALS, LLCSimilar federal contract value in Medtech · null in contracts
  • AVANT GENOMICS, LLCSimilar federal contract value in Medtech · null in contracts
  • BLOOM SURGICAL, INC.Similar federal contract value in Medtech · null in contracts
  • VERSAMETRICS LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .